Revelation Biosciences, Inc.

REVB ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
SC 13G/A Feb 14, 2022 KARPUS INVESTMENT MGT / REVELATION BIOSCIENCES - SCHEDULE 13G/A(#1)
SC 13G/A Feb 11, 2022 FORM SC 13G/A
8-K Feb 11, 2022 CURRENT REPORT
4 Feb 10, 2022 FORM 4 SUBMISSION
424B3 Feb 10, 2022 PROSPECTUS
4/A Feb 9, 2022 FORM 4/A SUBMISSION
SC 13G Feb 9, 2022
4 Feb 8, 2022 FORM 4 SUBMISSION
EFFECT Feb 7, 2022
SC 13G/A Feb 4, 2022 PAIC 13G/A
CORRESP Feb 3, 2022
CORRESP Feb 3, 2022
UPLOAD Feb 2, 2022
CORRESP Jan 28, 2022
S-1 Jan 28, 2022 REGISTRATION STATEMENT
8-K Jan 27, 2022 CURRENT REPORT
3 Jan 20, 2022 FORM 3 SUBMISSION
3 Jan 20, 2022 FORM 3 SUBMISSION
3 Jan 20, 2022 FORM 3 SUBMISSION
3 Jan 20, 2022 FORM 3 SUBMISSION
3 Jan 20, 2022 FORM 3 SUBMISSION
3 Jan 20, 2022 FORM 3 SUBMISSION
SC 13G Jan 20, 2022 SC 13G
8-K Jan 14, 2022 CURRENT REPORT
8-K Jan 13, 2022 CURRENT REPORT
← Newer Page 12 of 16 · 387 filings Older →